The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SHR2554, an enhancer of zeste homolog 2 (EZH2) inhibitor, in relapsed or refractory (r/r) mature lymphoid neoplasms: A first-in-human phase 1 study.
 
Yuqin Song
No Relationships to Disclose
 
Yanyan Liu
No Relationships to Disclose
 
Zhi-Ming Li
No Relationships to Disclose
 
Lanfang Li
No Relationships to Disclose
 
Hang Su
No Relationships to Disclose
 
Zhengming Jin
No Relationships to Disclose
 
Xuelan Zuo
No Relationships to Disclose
 
Jianyuan Wu
No Relationships to Disclose
 
Hui Zhou
No Relationships to Disclose
 
Kunyan Li
No Relationships to Disclose
 
Chuan He
No Relationships to Disclose
 
Jianfeng Zhou
No Relationships to Disclose
 
Junyuan Qi
No Relationships to Disclose
 
Siguo Hao
No Relationships to Disclose
 
Zhen Cai
No Relationships to Disclose
 
Yijing Li
Employment - Jiangsu Hengrui Pharmaceuticals
 
Weiwei Wang
Employment - Jiangsu Hengrui Pharmaceuticals
 
Xiaojing Zhang
Employment - Jiangsu Hengrui Pharmaceuticals
 
Jianjun Zou
Employment - Jiangsu Hengrui Pharmaceuticals Co, Ltd.
 
Jun Zhu
No Relationships to Disclose